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Abstract
Sixteen cases of nasopharyngeal
carcinoma (eight anaplastic and eight
well differentiated squamous types) were
examined for the presence of human
papillomavirus types 16 and 18 genomes
using the polymerase chain reaction on
paraffinwaxembeddedbiopsy specimens.
Although nasopharyngeal carcinoma,
particularly the anaplastic type, is
strongly associated with Epstein-Barr
virus, other factors may be involved in
its pathogenesis. No DNA of either
human papillomavirus subtype was
detected. It is concluded, therefore, that
these two "high risk" types of human
papillomavirus are not implicated in the
pathogenesis of nasopharyngeal carcin-
oma. The number of cases in this series
was small, however, and further studies
are warranted using fresh biopsy
material and including other viral sub-
types.
Using molecular biology techniques, human
papillomavirus (HPV), particularly type 16
has been found to be associated with some
types of squamous carcinomas of the upper
aerodigestive tract.`'3 No attempt has been
made thus far, however, to detect the presence
of the HPV genome in nasopharyngeal
carcinoma, common in Hong Kong Chinese
people. We therefore decided to analyse a
small series of cases of nasopharyngeal
carcinoma for HPV 16 and 18, the types most
commonly associated with malignancy in
humans,4 using the polymerase chain reaction
(PCR). This method was selected because of
its sensitivity, specificity, and its suitability for
use with small, paraffin wax embedded biopsy
specimens.
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Methods and results
Sixteen cases of nasopharyngeal carcinoma,
eight anaplastic (WHO type 1) and eight well
differentiated squamous (WHO type 3), were
selected from the files of the Department of
Pathology, University of Hong Kong. The
slides were reviewed and the original diagnoses
confirmed. DNA was extracted from dewaxed
sections of the biopsy material. The oligo-
nucleotide primers used in the PCR for HPV
16 were complementary to the upstream
regulatory region5 of the viral DNA, while
for HPV 18 they were complementary to
sequences in the E6 region6 (table). These
regions were chosen because they are almost
always retained even if the HPV DNA is
integrated in tumours. In each case three 16 ,um
thick sections were cut from the paraffin wax
embedded tissues and were dewaxed with
sequential washes of xylene, 95% ethanol, and
absolute ethanol and then vacuum dried. The
sections were resuspended in 63-5 yl of 0 1 mm
EDTA, boiled for 11 minutes, and snap cooled
to 0°C to release and denature theDNA before
PCR analysis. Amplifications ofHPV 16 or 18
targetDNA sequences were carried out using a
DNA amplification kit (Perkin Elmer Cetus)
and programmable thermal controller under
the following conditions: initial template
denaturation at 94°C for 1-5 minutes followed
by annealing at 37°C for two minutes,
extension at 72°C for three minutes, and
denaturation at 94°C for one minute. This
sequence was repeated for a total of 39 cycles.
For the fourtieth cycle annealing was followed
by prolonged extension for 10 minutes at 72°C.
The amplified products were heated at 68°C for
five minutes, snap cooled at 0°C, and were
analysed by gel electrophoresis in 4% agarose.
The gels were subsequently stained with
ethidium bromide and photographed under
ultraviolet light. No HPV DNA of types 16 or
18 was noted in any of the 16 cases or the
negative controls, only in the positive control.
CaSki and HeLa cell lines DNA were used as
positive controls for HPV 16 and 18, respec-
tively. The negative control consisted of a
typical PCR reaction mix without the template
DNA. Control primers were successfully
amplified in these PCR reactions, verifying that
there were no inhibitory elements present in
the extracted DNA. The amplified products
were further analysed by Southern blotting of
the gel followed by probing of the membrane
Sequences of oligonucleotide primers
Genomic Size of amplified
HPV type Sequence (5'-> 3') location product (base pairs)
HPV 16 A: AAG GCC AAC TAA ATG TCA C (19-mers) 7763-7781 228
B: GCG GAT CCT GTC TGC TTT TAT ACT AA (26-mers) 61-86
HPV 18 A: ACC TTA ATG AAA AAC CACGA (20-mers) 371-390 100
B: CGT CGT TGG AGT CGT TCCTG (20-mers) 451-470
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4% agarose gels stained with ethidium bromide showing absence ofPCR amplified DNA
products ofHPV 16 andHPV 18 in cases 1-8from anaplastic (A) and in cases 9-16
from well differentiated squamous (B) nasopharyngeal carcinoma. HpaII digested
pUC19 DNA was used as marker.
with 32P-labelled genomic probes specific for
HPV 16 and 18 DNA which confirmed the
above results. The hybridisation and washing
conditions were identical with those previously
reported by our laboratory.7
Discussion
Nasopharyngeal carcinoma is a major health
problem among Hong Kong Chinese, and in
1987, the most recent year for which official
figures are available, 1099 new cases were
notified to the Hong Kong Cancer Registry,
from a population of about 5-5 million, making
it the second commonest malignancy reported
that year. The common anaplastic form
("lymphoepithelioma" type, WHO type 3) has
long been known to have a strong association
with Epstein-Barr virus (EBV), and viralDNA
has recently been demonstrated in the tumour
cells by in situ hybridisation techniques.89
The much less common, well differentiated
squamous variety (WHO type 1), however,
which accounts for about 2% of the cases seen
in our department, has a less clearly defined
association with EBV and might also,
theoretically, be more likely to be related to
HPV infection because of its differentiation.
Moreover, other factors have been postulated
as aetiological agents-carcinogens and
mutagens in salted fish consumed in child-
hood.10 It would not be unreasonable to
postulate, therefore, that the "high risk"
human papillomaviruses might be involved. As
is clearly shown in the figure, however, no HPV
DNA of types 16 or 18 was detectable in any of
our 16 cases of nasopharyngeal carcinoma
studied. The PCR is an extremely sensitive
method for detecting specific DNA sequences,
and in theory requires only a single copy of the
target sequence. In our laboratory we have had
no difficulty detecting the EBV genome using
this method in cases of anaplastic nasopharyn-
geal carcinoma on paraffin wax embedded
material (Dickens P, et al unpublished observa-
tions). We conclude that HPV types 16 and 18
do not seem to be implicated in the patho-
genesis of nasopharyngeal carcinoma of ana-
plastic or well differentiated squamous types,
although the number of cases in this series is
small. It would be interesting, however, to
study a larger number of cases using fresh
biopsy material and also look for a wider range
ofHPV subtypes.
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